Comparative assessments of crucial factors for a functional ligand-targeted nanocarrier

Journal of Drug Targeting

Volumn 22, Issue 7, 2014, Pages 600-609

  Hossen, Md Nazir ^a   Kajimoto, Kazuaki ^a   Tatsumi, Ryo ^a   Hyodo, Mamoru ^a   Harashima, Hideyoshi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Active targeting; CD spectrum; Fixed aqueous layer thickness; Ligand; Liposomes; Peptide; Secondary structure

Indexed keywords

CYTOCHROME C; LIGAND; LIGAND TARGETED NANOCARRIER; LIPOSOME; NANOCARRIER; NANOPARTICLE; ORGANIC SOLVENT; PROHIBITIN; UNCLASSIFIED DRUG; DRUG CARRIER; OLIGOPEPTIDE; PROTEIN BINDING; REPRESSOR PROTEIN;

ADIPOSE TISSUE CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CIRCULAR DICHROISM; COMPARATIVE STUDY; CONFORMATION; CONTROLLED STUDY; DENSITY; DRUG DELIVERY SYSTEM; DRUG TARGETING; EVAPORATION; HYDRATION; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; LIPID DIET; LIPID MEMBRANE; MALE; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NONHUMAN; OBESITY; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; SURFACE PROPERTY; ZETA POTENTIAL; ADIPOSE TISSUE; ANIMAL; C57BL MOUSE; CHEMISTRY; CONFOCAL MICROSCOPY; CYTOLOGY; DISEASE MODEL; DRUG FORMULATION; ENDOTHELIUM CELL; METABOLISM; PROCEDURES; VASCULARIZATION;

ADIPOSE TISSUE; ANIMALS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DRUG CARRIERS; DRUG COMPOUNDING; ENDOTHELIAL CELLS; LIGANDS; MALE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; NANOPARTICLES; OBESITY; OLIGOPEPTIDES; PARTICLE SIZE; PROTEIN BINDING; REPRESSOR PROTEINS; SURFACE PROPERTIES;

EID: 84904305472     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2014.915552     Document Type: Article

References (26)

1. Hua S, Wu SY. The use of lipid-based nanocarriers for targeted pain therapies. Front Pharmacol 2013;4:143. doi: 10.3389/ fphar.2013.00143
2. Willis M, Forssen E. Ligand-Targeted liposomes. Adv Drug Deliv Rev 1998;29:249-71
3. Chen Z, Deng J, Zhao Y, Tao T. Cyclic RGD peptide-modified liposomal drug delivery system: Enhanced cellular uptake in vitro and improved pharmacokinetics in rats. Int J Nanomedicine 2012;7: 3803-11
4. Emanuel N, Kedar E, Bolotin EM, et al. Targeted delivery of doxorubicin via sterically stabilized immunoliposomes: Pharmacokinetics and biodistribution in tumor-bearing mice. Pharm Res 1996;13:861-8
5. Iinuma H, Maruyama K, Okinaga K, et al. Intracellular targeting therapy of cisplatin-encapsulated transferrin-polyethylene glycol liposome on peritoneal dissemination of gastric cancer. Int J Cancer 2002;99:130-7
6. Turk MJ, Waters DJ, Low PS. Folate-conjugated liposomes preferentially target macrophages associated with ovarian carcinoma. Cancer Lett 2004;213:165-72
7. Hossen MN, Kajimoto K, Akita H, et al. Ligand-based targeted delivery of a peptide modified nanocarrier to endothelial cells in adipose tissue. J Control Release 2010;147:261-8
8. Kolonin MG, Saha PK, Chan L, et al. Reversal of obesity by targeted ablation of adipose tissue. Nat Med 2004;10:625-32
9. Hossen MN, Kajimoto K, Akita H, et al. Vascular-Targeted nanotherapy for obesity: Unexpected passive targeting mechanism to obese fat for the enhancement of active drug delivery. J Control Release 2012;163:101-10
10. Hossen MN, Kajimoto K, Akita H, et al. Therapeutic assessment of cytochrome C for the prevention of obesity through endothelial cell-Targeted nanoparticulate system. Mol Ther 2013;21:533-41
11. Hossen N, Kajimoto K, Akita H, et al. A comparative study between nanoparticle-Targeted therapeutics and bioconjugates as obesity medication. J Control Release 2013;171:104-12
12. Kajimoto K, Hossen MN, Harashima H. Antiangiogenic nanotherapy for the control of obesity. Nanomedicine (Lond) 2013;8:671-3
13. Zalba S, Navarro I, Troconiz IF, et al. Application of different methods to formulate PEG-liposomes of oxaliplatin: Evaluation in vitro and in vivo. Eur J Pharm Biopharm 2012;81: 273-80
14. Bangham AD, Standish MM, Watkins JC. Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 1965; 13:238-52
15. Meure LA, Foster NR, Dehghani F. Conventional and dense gas techniques for the production of liposomes: A review. AAPS PharmSciTech 2008;9:798-809
16. Szoka Jr. F, Papahadjopoulos D. Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse-phase evaporation. Proc Natl Acad Sci USA 1978;75: 4194-8
17. Israelachvili J. Intermolecular and surface forces. London: Academic Press; 1985
18. Verwey EJ, Overbeek JTG. Theory of the stability of lyophobic colloids. Amsterdam: Elsevier; 1948
19. Sadzuka Y, Hirota S. Physical properties and tissue distribution of adriamycin encapsulated in polyethyleneglycol-coated liposomes. Adv Drug Deliv Rev 1997;24:257-63
20. Shimada K, Miyagishima A, Sadzuka Y, et al. Determination of the thickness of the fixed aqueous layer around polyethyleneglycolcoated liposomes. J Drug Target 1995;3:283-9
21. Kajimoto K, Hossen MN, Hida K, et al. Isolation and culture of microvascular endothelial cells from murine inguinal and epididymal adipose tissues. J Immunol Methods 2010;357:43-50
22. Nagle JF, Tristram-Nagle S. Structure of lipid bilayers. Biochim Biophys Acta 2000;1469:159-95
23. Garbuzenko O, Barenholz Y, Priev A. Effect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer. Chem Phys Lipids 2005;135:117-29
24. Sadzuka Y, Nakade A, Hirama R, et al. Effects of mixed polyethyleneglycol modification on fixed aqueous layer thickness and antitumor activity of doxorubicin containing liposome. Int J Pharm 2002;238:171-80
25. Park J, Mattessich T, Jay SM, et al. Enhancement of surface ligand display on PLGA nanoparticles with amphiphilic ligand conjugates. J Control Release 2011;156:109-15
26. Tsai CS, ed. Studies of biomacromolecular structures: Spectroscopic analysis of conformation. In: Biomacromolecules: Introduction to structure, function and informatics. Hoboken (NJ): John Wiley & Sons, Inc.; 2006:183-219.